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INTRODUCTION
Developing neurons send out processes that reach their targets
guided mostly by extracellular cues that are either permissive,
attractive and growth promoting, or repulsive and inhibitory
(Chilton, 2006; Dickson, 2002; Huber et al., 2003). Several
evolutionarily conserved families of guidance and cell adhesion
molecules have been identified (Chilton, 2006; Dickson, 2002;
Huber et al., 2005). Selective fasciculation and defasciculation
regulated by interaxonal adhesion and repulsion from surrounding
tissues help to define accurate axonal projections, e.g. by cell
adhesion molecules (CAMs) on the surface of axons (Rutishauser,
2008; Van Vactor, 1998). Thus, spatial and temporal modulation of
neural cell adhesion molecule (NCAM) activity by polysialic acid
(PSA) regulates sorting of motor axons and peripheral nerve
formation during innervation of the vertebrate limb (Rafuse and
Landmesser, 2000). Ephrins, semaphorins and slits are thought to
promote fasciculation by creating a repulsive environment that
channels axons and prevents them from entering into non-target
areas (Chilton, 2006; Eberhart et al., 2000; Huber et al., 2005).
Removal of these repulsive cues or their neuronally expressed
receptors leads to defasciculation and guidance errors.
An important growth cone collapsing and growth inhibitory
protein in the adult central nervous system (CNS) is Nogo-A
(also known as Rtn4). The protein is mainly known for its
inhibitory effects on axon regeneration and compensatory
sprouting after CNS injury (Schwab, 2004; Yiu and He, 2006).
In the adult CNS Nogo-A is expressed primarily by
oligodendocytes and myelin (Caroni and Schwab, 1988; Huber
et al., 2002; Wang et al., 2002). Nogo-A affects the cytoskeleton
by binding to a receptor complex containing NgR (also known
as Rtn4r), p75/TROY and Lingo1, and activating the small
GTPase RhoA and ROCK (Fournier et al., 2003; Montani et al.,
2009; Yiu and He, 2006). In addition to its glial expression in the
adult, Nogo-A is expressed by many peripheral and central
neurons during development (Huber et al., 2002; Hunt et al.,
2003; Josephson et al., 2001; Wang et al., 2002). An early
developmental role in the restriction of migration of cortical
interneurons has been described (Mingorance-Le Meur et al.,
2007). Later in development, Nogo-A is involved in restricting
plasticity in the visual cortex and other parts of the CNS
(Kapfhammer and Schwab, 1994; McGee et al., 2005).
Here, we show that suppression of Nogo-A signalling leads to
increased neurite outgrowth, increased fasciculation, and decreased
branching in cultured dorsal root ganglion (DRG) neurons. In the
chicken embryo, in ovo injection of function-blocking anti-Nogo-
A antibodies led to highly bundled peripheral nerves with reduced
branching. Similar changes were observed in Nogo-A knock-out
(KO) mouse embryos. These observations suggest that Nogo-A
acts as a negative regulator of axon-axon adhesion contributing to
the regulation of fasciculation and the branching of fibre tracts
during nervous system development.
MATERIALS AND METHODS
Animals
Embryonic and newborn (P0-P1) C57Bl/6 wild-type and Nogo-A KO
mice, C57BL/6-Tg(ACTB-EGFP)1Osb/J mice (Jackson; eGFP cDNA
under the control of a chicken -actin promoter), neonatal Wistar rats, and
embryonic chicks were used in this study. All animal experiments were
performed according to the guidelines of the Veterinary Office of the
Canton of Zürich, Switzerland, and approved by its Commission for
Animal Research.
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SUMMARY
Wiring of the nervous system is a multi-step process involving complex interactions of the growing fibre with its tissue
environment and with neighbouring fibres. Nogo-A is a membrane protein enriched in the adult central nervous system (CNS)
myelin, where it restricts the capacity of axons to grow and regenerate after injury. During development, Nogo-A is also
expressed by neurons but its function in this cell type is poorly known. Here, we show that neutralization of neuronal Nogo-A or
Nogo-A gene ablation (KO) leads to longer neurites, increased fasciculation, and decreased branching of cultured dorsal root
ganglion neurons. The same effects are seen with antibodies against the Nogo receptor complex components NgR and Lingo1, or
by blocking the downstream effector Rho kinase (ROCK). In the chicken embryo, in ovo injection of anti-Nogo-A antibodies leads
to aberrant innervation of the hindlimb. Genetic ablation of Nogo-A causes increased fasciculation and reduced branching of
peripheral nerves in Nogo-A KO mouse embryos. Thus, Nogo-A is a developmental neurite growth regulatory factor with a role
as a negative regulator of axon-axon adhesion and growth, and as a facilitator of neurite branching.
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Nogo-A KO mice were generated by homologous recombination of
exons 2 and 3 in the Nogo-A gene, as described previously (Dimou et al.,
2006; Simonen et al., 2003).
Antibodies
11C7 antibody was raised against an 18-amino acid Nogo-A peptide
corresponding to the rat sequence of amino acids 623-640 (Oertle et al.,
2003). 7B12 antibody has an epitope in the C-terminal part of the Nogo-
A-specific region (aa 763-820) (Oertle et al., 2003). Both antibodies are
function-blocking antibodies (Liebscher et al., 2005) and are monospecific
for Nogo-A (Dodd et al., 2005; Oertle et al., 2003). Polyclonal rabbit
antibody Rb173A (Laura) recognizes the Nogo-A-specific region (aa 174-
979) and the antibody Rb1 (Bianca) is specific for the N terminus of Nogo-
A and Nogo-B (aa 1-172) (Dodd et al., 2005; Oertle et al., 2003). Nogo-A
receptor complex components were blocked by anti-NgR (R&D Systems)
or anti-Lingo1 (Abcam) antibodies. Compound Y27632 was used to inhibit
ROCK (Sigma). Rabbit anti-neurofilament 160 antibody (Chemicon) was
used for whole-mount staining and mouse anti--tubulin III (Abcam) was
used for staining of dissociated DRG cultures.
DRG cultures
DRG explant cultures
DRGs of newborn rats, wild-type and Nogo-A KO mice were plated on 20
g/ml poly-L-lysine (PLL)-coated four-well tissue culture plates. Cultures
were incubated for 5-7 days at 37°C and 5% CO2 atmosphere in F12
medium (Invitrogen) supplemented with 10% foetal bovine serum (Sigma),
100 g/ml nerve growth factor (NGF) and 10 g/ml gentamycin (Sigma).
Cytosine arabinoside was added to inhibit mitosis of non-neuronal cells.
Control, monoclonal mouse IgG antibody directed against wheat auxin,
anti-Nogo-A antibodies 11C7 or 7B12, antibodies against NgR-1 or Lingo1
or the ROCK blocker Y27632 were added to the culture medium at a
concentration of 10 g/ml at the beginning of the culturing period.
Dissociated DRG cultures
DRG neuron cultures of newborn wild-type and Nogo-A KO mice were
prepared as previously described (Montani et al., 2009).
Transduction of primary DRG neurons
Neonatal Nogo-A KO mouse DRG neurons were infected at the time of
plating for 10-24 hours with either AAV2.eGFP or AAV2.Nogo-A at a
multiplicity of infection (MOI) of 1. Transduction efficiency was assessed
by immunostaining against either eGFP or Nogo-A.
Electron microscopy
Transmission and scanning electron microscopy experiments were
performed as described previously (Aloy et al., 2006; Rutishauser et al.,
1978).
Immunoblotting
Western blots of mouse brain lysates and DRG neurons were carried out
as previously described (Montani et al., 2009) and, for quantification,
protein band intensities were normalized to GAPDH values.
Quantitative real-time PCR
DRGs from mice of different ages ranging from E15-P60 were rapidly
dissected in RNAlater solution (Ambion). The RNA was prepared with the
RNeasy Micro Kit (QIAGEN). Residual genomic DNA was digested by
DNase treatment. For reverse transcription, the same amounts of total RNA
were transformed by oligo-dT and M-MLV reverse transcriptase
(Promega). For all tissues, cDNAs corresponding to 5 ng of total RNA
were amplified with specific primers designed to span intronic sequences
or to cover exon-intron boundaries.
Primers specific for NgR (forward, 5-CTCGACCC CGAAGATGAAG;
reverse, 3-TGTAGCACACACA AGCAC CAG) were used. Gene
expression was analyzed by real-time reverse transcription (RT)-PCR with
a polymerase ready mix (LightCycler 480; SYBR Green I Master; Roche
Diagnostics) and a thermocycler (LightCycler; Roche). Analysis of the
melting curve of each amplified PCR product and visualization of the PCR
amplicons on 1.5% agarose gels allowed the specificity of the amplification
to be controlled. For relative quantification of gene expression, mRNA
levels were normalized to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and -actin using the comparative threshold cycle (CT)
method. Each reaction was carried out in triplicate.
Time-lapse video microscopy
Images were taken with a cooled digital CCD Hamamatsu Orca camera
attached to the inverted widefield Leica DM IRBE microscope equipped
with a 10 phase contrast objective (NA 0.3) and an environmental
chamber maintained at 37°C and 5% CO2 atmosphere. Images were
acquired every 5 minutes over an observation period of 10-20 hours and
subsequently assembled into movies with the OpenLab 3.1.7 and
QuickTime (Apple) (0.10 seconds/frame) software.
Immunofluorescence staining of DRG neurons
Surface staining
Dissociated DRGs were plated on PLL- and laminin-coated glass
coverslips. After 24 hours in culture, living cells were washed with room
temperature PBS and subsequently transferred on a cold metal plate (10-
14°C), where they were rinsed with cold PBS containing 1 mM CaCl2
and 0.5 mM MgCl2. After the blocking step, primary antibody (anti-
Nogo-A Ab Rb173A; anti-Phaseolus vulgaris agglutinin) diluted to 100
g/ml in cold blocking TNB buffer (0.1 Casein, 0.25% BSA, 0.25%
TopBlock in TBS) was added to live cells for 20 minutes. After rinsing
with cold TBS cells were fixed with 4% paraformaldehyde (PFA) for 20
minutes at room temperature. Following incubation with secondary
antibody, FITC-conjugated streptavidin was applied for 30 minutes. The
cells were then washed three times with TBS and mounted on slides
with Mowiol [10% Mowiol 4-88 (w/v) (Calbiochem) was dissolved in
100 mM Tris (pH 8.5) with 25% glycerol (w/v), and 0.1% 1,4-
diazabicyclo[2.2.2]octane (DABCO) was added as an anti-bleaching
reagent].
Confocal imaging was performed using a Spectral Confocal Microscope
TCS SP2 AOBS (Leica) and a 63 oil immersion objective (HCX PL
APO Oil, NA 1.32). Confocal image acquisition consisted of four images
of z-dimension with a step size of 1 m and image size of 0.1 m/pixel
(10241024). The pinhole was set at 1 Airy unit. Double-
immunofluorescence staining was visualized by sequential acquisition of
separate colour channels to avoid cross-talk between fluorochromes.
In order to confirm the intactness of the cells and the specificity of the
Nogo-A surface staining, antibody against -tubulin III was used with or
without permeabilization (for intracellular and surface staining,
respectively; described above) of cell membrane.
To confirm the confocal microscopy results, we performed pre-
embedding immunoelectron microscopy using colloidal gold. Cells were
quenched in 1% NaBH4, blocked with IgG-free BSA (Jackson
ImmunoResearch Laboratories) for 1 hour and incubated with the primary
antibody (as described in the above section). Following incubation with the
secondary antibody, cells were treated with 10-nm colloidal gold particles
conjugated with Protein A (BBInternational) and processed for routine
plastic embedding. Ultra-thin sections were analyzed with a Zeiss electron
microscope EM10 and images were taken with a GATAN camera.
Intracellular staining
Dissociated DRGs plated on PLL- and laminin-coated glass coverslips and
cultured for either 10 or 24 hours were washed with PBS and fixed with
4% PFA for 20 minutes. After permeabilization with 0.3% Triton X-100
and washing with PBS, cells were incubated in blocking buffer (2% goat
serum, 0.2% fish skin gelatine in PBS) and subsequently with primary
antibody for 30 minutes. Following 30 minutes incubation with secondary
antibody, coverslips were mounted on slides with Mowiol containing 0.1%
DABCO. For lower magnification imaging, cultures were imaged with an
AxioCam HRm (Zeiss) camera coupled to a Zeiss Axioskop 2 equipped
with a 10 objective (Plan NEOFLUAR, NA 0.3). Confocal imaging was
done as described in the above section.
Immunohistochemistry
Tissue sections were permeabilized and incubated with a blocking buffer
(3% donkey serum, 0.3% Triton X-100 in TBS) for 30 minutes at room
temperature. Primary antibody was applied overnight at 4°C and, after











washing with TBS, sections were incubated with the secondary antibody
for 2 hours at room temperature. Finally, sections were counterstained with
Hoechst dye and mounted with Mowiol.
In ovo injections of anti-Nogo-A antibodies
Fertilized eggs obtained from a local hatchery were incubated at 38.5-39°C
and staged according to Hamburger and Hamilton (Hamburger and
Hamilton, 1951). Anti-Nogo-A antibody 11C7 (1 l; 1.7 mg/ml) or a
control antibody was injected into the limb bud three times over 36 hours.
The ROCK inhibitor Y27632 was diluted in PBS and 0.04% Trypan Blue
to the final concentration of 6.7 g/ml and 1 l was injected three times
over 36 hours. Embryos were sacrificed at HH26, fixed in 4% PFA, and
stained as wholemounts with an anti-neurofilament 160 antibody, as
previously described (Perrin and Stoeckli, 2000).
To determine the distribution of the injected antibody, some embryos
were fixed in 4% PFA 4 hours after the last injection of the 11C7 anti-
Nogo-A antibody. These embryos were subsequently processed with Cy3-
conjugated goat anti-mouse secondary antibody to visualize the injected
11C7 antibody.
In order to assess the specificity of our function-blocking anti-Nogo-A
antibody 11C7, and to rule out the possibility of sterical shielding of
unspecific epitopes, we injected several embryos with an antibody against
the immunoglobulin superfamily adhesion molecule SC1 (also known as
BEN) (Pourquie et al., 1990). Depletion of BEN showed no effect on
fasciculation and pathfinding of motor axons in the developing chick
hindlimb (Fig. 6I).
Analysis of fore- and hindlimb innervation pattern in Nogo-A KO
mouse embryos
To visualize the complete set of nerves innervating the developing limbs,
E12.5, E13.5 and E15.5 wild-type and Nogo-A KO mouse embryos were
collected and processed for whole-mount immunohistochemistry with anti-
neurofilament 160 antibody, as previously described (Maina et al., 1997).
In situ hybridization
For in situ hybridization analysis, digoxigenin (DIG)-labeled sense and
antisense cRNA probes complementary to chicken and mouse Nogo-A
sequences were prepared from a 316 bp-long fragment of chicken Nogo-
A (bp 1343-1659) and by using the mouse Nogo-A exon three sequence
(2361 bp), which encodes the main neurite outgrowth and cell spreading-
inhibitory region of this protein. In situ hybridization was performed as
previously described (Schaeren-Wiemers and Gerfin-Moser, 1993).
RESULTS
Neutralization or genetic ablation of Nogo-A
enhances neurite outgrowth and fasciculation in
DRG explant cultures
To assess the role of Nogo-A in developing neurons, we analyzed
the neurite outgrowth of neonatal mouse and rat DRG explants in
the presence of function-blocking, monospecific anti-Nogo-A
monoclonal antibodies (11C7 or 7B12) or a control antibody. The
neurite outgrowth pattern was analyzed by determining the average
length of the 10 longest neurites per DRG, defasciculation points
were counted at a distance of 300 m from the DRG, and the
percentage of thin (0.4–1.2 m), intermediate (1.3–4 m), and
thick (4.1–15 m) neurite fascicles that emerged from the ganglion
surface was determined (Rutishauser et al., 1978).
The presence of either 11C7 or 7B12 anti-Nogo-A antibody in
the medium of DRG explant cultures (5-7 days in vitro) resulted in
a dramatic change in the morphology and the diameter of the
neurite halo (Fig. 1A). Anti-Nogo-A antibody treatment doubled
the length of radial outgrowth (Fig. 1B) and led to a reduction in
the number of defasciculation points at 300 m from DRG edges
(Fig. 1C). A marked shift from predominantly thin to thick fascicles
extending from DRGs was observed in the presence of either the
11C7 or the 7B12 anti-Nogo-A antibody (Fig. 1D).
The effects of anti-Nogo-A antibodies on neurite outgrowth
and morphology were dose dependent with maximal results
obtained with an antibody concentration of 10 g/ml (see Table
S1 in the supplementary material). One third of this
concentration still produced a detectable shift from thin to thick
fascicles, but higher amounts of antibodies did not increase the
differences in neurite morphology (see Table S1 in the
supplementary material). When these function-blocking anti-
Nogo-A antibodies were applied in neonatal rat DRG explant
cultures, very similar results to the ones shown here for mouse
DRGs were obtained (data not shown).
To investigate the possibility that ganglia from different parts of
the spinal column vary in their response to anti-Nogo-A antibodies,
cervical, thoracic and lumbar DRGs from newborn mice were
cultured in medium containing either control or anti-Nogo-A
antibodies (11C7 or 7B12). The effects of Nogo-A neutralizing
antibodies on the length and fasciculation of neurites emanating
from the DRG explants were comparable for all the spinal levels
(see Table S2 in the supplementary material).
As an alternative to acute ablation of Nogo-A by function-
blocking anti-Nogo-A antibodies, we used DRGs from neonatal
Nogo-A KO mice. The pattern of neurites growing out from Nogo-
A KO DRGs was strikingly different from that of wild-type DRGs,
but very similar to that of DRGs treated with anti-Nogo-A
antibodies (Fig. 1A): a two-fold increase in the length of radial
outgrowth compared with wild-type DRG explants (Fig. 1B); a
severely reduced number of defasciculation points (Fig. 1C); and
an increased fraction of thick fascicles emanating from the ganglia
(Fig. 1D).
In order to confirm that the effects of function-blocking anti-
Nogo-A antibodies 11C7 and 7B12 on neurite outgrowth from
wild-type DRGs were specific, we applied the antibodies to
cultures of Nogo-A KO DRGs. The measured parameters were
indistinguishable from those seen in non-treated Nogo-A KO DRG
cultures (Fig. 1B-D), thus confirming the specificity of the anti-
Nogo-A antibody effects. In western blots, both monoclonal anti-
Nogo-A antibodies recognized a single band corresponding to
Nogo-A at a molecular mass of ~190 kDa (see Fig. S1A in the
supplementary material).
Scanning and transmission electron microscopy (TEM)
observations confirmed the effects of function-blocking anti-Nogo-
A antibodies on DRG neurites: straight, thick fascicles with a
reduced ability to defasciculate from each other, rather than
networks of fine, interlaced processes, were consistently seen when
the function of Nogo-A was blocked (Fig. 2A,B). As shown in Fig.
2C,D, treatment of wild-type DRGs with the anti-Nogo-A antibody
11C7 caused a marked increase in the average number of neurites
per fibre bundle when compared with the control antibody-treated
cultures.
Neutralization of Nogo-A alters branching and
elongation of dissociated DRG neurons
In order to investigate whether Nogo-A plays a role in neurite
elongation and branching of single cells, we cultured dissociated
DRG neurons from wild-type neonatal mice for 10-24 hours in
the presence of either 11C7 or 7B12 Nogo-A neutralizing
antibodies. Length of the longest neurite, total neurite length,
rectilinearity of neurites, length of the primary neurites before
the first branch point, number of primary neurites per
neuron, number of branch points per neuron, and the size of
branch angles between the daughter and parent neurite were
quantified.












Upon neutralization of Nogo-A, dissociated DRG neurons sent
out significantly longer individual neurites than when treated with
control antibody (Fig. 3A,B). In addition, these neurites appeared
to be straighter than the control antibody-treated ones (Fig. 3A).
The rectilinearity index [the ratio between the length of a straight
line between the origin and the distal end of the neurite and its
actual length (Bouquet et al., 2004)] showed that neurites of anti-
Nogo-A antibody-treated cells were much straighter (11C7,
0.937±0.0198, n89; 7B12, 0.942±0.031, n83) than the control
antibody-treated neurons, which exhibited a more wavy growth
(0.787±0.0287, n82; P<0.001).
Interestingly, the sum of the length of all neurites per neuron was
almost identical among all treated groups (Fig. 3C), as was the
number of primary neurites (control antibody, 3.63±0.17, n82;
11C7, 3.59±0.21, n89; 7B12, 3.78±0.18, n83). The increased
length of individual neurites was therefore mainly due to the
reduction in branching, which was observed as a decrease in the
number of branch points per neuron in the anti-Nogo-A antibody-
treated cultures (Fig. 3D). In addition, the presence of anti-Nogo-
A antibodies caused the first branch points to occur further away
from the cell body than in control antibody-treated cultures (control
antibody, 10.79±1.14 m, n82; 11C7, 23.42±1.914 m, n89;
7B12, 25.38±2.324 m, n83; P<0.0001).
We also measured the angles formed by the branches with their
neurites of origin. Collateral branches usually form at almost right
angles (90°) from the parent neurite (Kalil et al., 2000). In control
antibody-treated cultures, ~60% of the branches formed at an angle
of 81-90°; smaller angles of 40-80° were rare (~15% of branches;
Fig. 3E). In anti-Nogo-A antibody-treated neurons, the frequency
of 81-90° angles decreased to ~42%, whereas the fraction of small
angle branches increased to ~30% compared with control antibody-
treated cells (Fig. 3E). These results suggest a reduction in the
repulsive interactions between neurites after neutralization of
Nogo-A.
Similar observations were made in cultures of dissociated Nogo-
A KO DRG neurons (Fig. 3A). Genetic ablation of Nogo-A
resulted in an increased length of the longest neurite (Fig. 3B), but
did not change the sum of neurite length per cell when compared
with that of wild-type cells (Fig. 3C). The rectilinearity index was
higher in Nogo-A KO DRG neurons than in wild-type controls
(0.926±0.0198, n81 versus 0.787±0.0287, n82; P<0.001), thus
confirming that the lack of Nogo-A leads to straighter neurite
trajectories (Fig. 3A). Nogo-A KO cells had significantly fewer
branch points per neuron than control cells (Fig. 3D), whereas the
number of primary neurites emanating from the cell body did not
show a significant difference (wild type, 3.63±0.17, n82; Nogo-
A KO, 3.68±0.16, n81). The length of the unbranched primary
neurites was increased in Nogo-A KO cells compared with in wild-
type controls (wild type, 10.79±1.14 m, n82; Nogo-A KO,
24.00±2.36 m, n81; P<0.0001). The percentage of branches
formed at large angles (81-90°) decreased in Nogo-A KO DRG
neurons from ~60% to ~44%, whereas the proportion of small
angle branches (40-80°) increased from ~17% to ~33% (Fig. 3E).
When anti-Nogo-A antibodies were added to cultures of Nogo-A
KO neurons, no additional effects were seen (Fig. 3B-E).
The specificity of these effects with regard to Nogo-A was
supported by rescue experiments in which Nogo-A KO DRG
neurons were transfected with adeno-associated viruses (AAV)
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Fig. 1. Neutralization of Nogo-A by
anti-Nogo-A antibodies or by genetic
ablation leads to an increase in the
length and fasciculation of neurites
in DRG explant cultures. (A)DRG
explants dissected from neonatal wild-
type (Control Ab) or Nogo-A KO mice
were cultured in the presence of either
control or anti-Nogo-A (11C7 or 7B12)
antibodies, or without any treatment.
Inactivation of Nogo-A resulted in the
outgrowth of longer, straighter and
thicker neurites, instead of the tangled
net of fine processes formed in the
control antibody-treated cultures. Scale
bar: 300m. (B)Inactivation of Nogo-A,
either by function-blocking antibodies or
by genetic ablation results in an
increased radial outgrowth length from
DRG explants. Antibodies had no effect
on Nogo-A KO neurons. (C)The number
of defasciculation points was decreased
in Nogo-A KO or anti-Nogo-A antibody-
treated wild-type DRGs. (D)Nogo-A
neutralization or knockout increased the
percentage of thick bundles emanating
from the DRGs. Control antibody-treated
wild-type DRGs did not differ
significantly from non-treated ones (data
not shown) and therefore are shown as
controls. Values represent means ±
s.e.m. of 39-59 ganglia per condition












serotype 2 (AAV2) expressing either green fluorescent protein
(eGFP) or Nogo-A (see Fig. S2A,B in the supplementary material).
Expression of Nogo-A rescued the Nogo-A KO phenotype: the
length of the longest neurite was decreased towards wild-type
values (see Fig. S2C in the supplementary material); the number of
branch points was increased (see Fig. S2E in the supplementary
material); and the rectilinearity index was lower in AAV2.Nogo-A
expressing neurons than in the plain Nogo-A KO ones
(0.796±0.0294, n89 versus 0.932±0.0193, n86, respectively;
P<0.001). The length of the unbranched primary neurites was
decreased in Nogo-A KO cells treated with AAV2.Nogo-A
compared with in AAV2.eGFP-treated controls (Nogo-A KO+
AAV2.Nogo-A, 11.23±1.19 m, n89; Nogo-A KO+AAV2.eGFP,
22.93±2.41 m, n86; P<0.0001). The percentage of branches
formed at large angles (81-90°) increased after expression of Nogo-
A in Nogo-A KO DRG neurons from ~45% to ~58%, whereas the
proportion of small angle branches (40-80°) decreased from ~36%
to ~20% (see Fig. S2F in the supplementary material).
As the experiments with dissociated DRG neurons suggested a
cell-autonomous effect, we prepared mixed cultures of wild-type
and Nogo-A KO DRG neurons in order to assess whether, upon
contact, they can affect the phenotype of one another. As shown in
Fig. S3A in the supplementary material, cell bodies of wild-type
and Nogo-A KO neurons did not associate with each other, but
rather made frequent contact with the cell of the same genotype
(see Fig. S3B,C in the supplementary material). In these cultures
~54% of cells were forming ‘doublets’ (two cell bodies touching
each other), ~32% were single cells, and ~14% of the cells were
making contacts with multiple cells. Because we could not assess
the phenotype of each cell in multi-cell conglomerates, we focused
on the ‘doublets’. Of all the doublets, ~57% were made by Nogo-
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Fig. 2. Neurite outgrowth from wild-type neonatal mouse and
rat spinal ganglia is highly fasciculated in the presence of anti-
Nogo-A antibody 11C7. (A,B)Scanning electron micrographs of
neurite outgrowth from newborn mouse lumbar DRGs. Control
antibody-treated DRG cultures show a typical, highly interlaced network
of fine neurites (A), whereas thick, well-spaced neurite bundles were
formed in the presence of anti-Nogo-A antibody 11C7 (B). Scale bar:
10m. (C)Ultrastructural analysis of cross-sectioned neurite bundles.
Scale bar: 0.2m. (D)Anti-Nogo-A antibody treatment increases the
number of neurites per fibre bundle. Values represent means ± s.e.m.
of 21-23 fibre bundles per condition from three independent
experiments; **P<0.001, Student’s t-test.
Fig. 3. Neutralization of Nogo-A leads to increased length and
reduced branching of DRG neurites. (A)Dissociated DRGs from
neonatal wild-type (Control Ab) or Nogo-A KO mice were cultured for
10-24 hours in the presence of either control or anti-Nogo-A (11C7 or
7B12) antibodies, or without any treatment. Neutralization of Nogo-A
resulted in the outgrowth of longer and straighter neurites with a
reduced number of branches. Scale bar: 50m. (B)Downregulation of
Nogo-A by either anti-Nogo-A antibodies or genetic ablation (Nogo-A
KO) resulted in an increased length of the longest neurites emanating
from the DRG neurons. (C)The total length of all neurites per neuron
was not affected by the absence of Nogo-A. (D)The number of branch
points per neuron was markedly reduced when Nogo-A was
inactivated. (E)Quantitation of the angles between the daughter and
parent neurite showed that the deletion of Nogo-A leads to a decrease
in the percentage of neurites forming branches at large (81-90°)
angles, and an increase in the proportion of neurites branching off at
small angles (40-80°). Control antibody-treated wild-type DRGs did not
differ significantly from non-treated ones (data not shown) and
therefore are shown as controls. Values represent means ± s.e.m. of
81-89 neurons per condition from four independent experiments;











A KO cells and 43% were formed by wild-type DRG neurons.
Mixed wild-type–Nogo-A KO doublets were not observed, which
suggests there are differences in adhesion/repulsion between the
two cell types.
Cultures of dissociated DRG neurons were used to verify the
presence of Nogo-A on the cell surface. Immunostaining of
dissociated, live neonatal mouse DRG neurons with a polyclonal,
monospecific rabbit antibody recognizing the Nogo-A specific
region [Rb173A/Laura (Dodd et al., 2005; Oertle et al., 2003)]
demonstrated punctate distribution of Nogo-A on the surface of
neuronal cell bodies and their processes (see Fig. S4B in the
supplementary material). The presence of Nogo-A on the cell
surface was further confirmed by immunogold electron
microscopy (see Fig. S4E in the supplementary material). Nogo-
A staining was completely absent on neurons of Nogo-A KO mice
(see Fig. S4C,F in the supplementary material). Additionally, NgR
mRNA was clearly present in DRG neurons from E15 to P60 (see
Fig. S4G in the supplementary material). Western blots confirmed
the expression of NgR protein in both wild-type and Nogo-A KO
DRG neurons at E15 (see Fig. S4H in the supplementary
material).
Antibodies against NgR or Lingo1, or blockade of
ROCK signalling, increases neurite fasciculation
and decreases branching of DRG neurons
Nogo-A has been shown to cause neurite growth inhibition and
growth cone collapse via a receptor complex including NgR,
p75/TROY and Lingo1 (Bandtlow and Dechant, 2004; Fournier et
al., 2001; Mi et al., 2004). Blockade of these components, or of
downstream Rho-A/ROCK activation, allows neurite outgrowth on
Nogo-A-containing substrates both in vitro and in vivo (Schwab,
2004; Yiu and He, 2006). When we applied antibodies against NgR
or Lingo1 to neonatal mouse DRG explants, neurites were longer
and were organized in well-spaced bundles with straight
trajectories (Fig. 4A,B). Additionally, a decrease in the number of
defasciculation points counted at 300 m from the DRG (Fig. 4C)
and a higher proportion of thick (4.1-15 m) fascicles (Fig. 4D)
were observed in these cultures. Inactivation of ROCK by Y27632
mimicked the results obtained following neutralization of its
upstream signalling partners, Nogo-A, NgR and Lingo1 (Fig. 4A),
and led to an increased length of radial outgrowth (Fig. 4B), a
twofold decrease in the number of defasciculation points at 300 m
from the DRGs (Fig. 4C), and an increase in the proportion of thick
fibre bundles growing out from the DRG (Fig. 4D). Almost
identical results as shown here for mouse DRGs were seen when
newborn rat DRG explants were used (data not shown).
The addition of anti-NgR, anti-Lingo1 or the ROCK blocker
Y27632 to cultures of dissociated DRG neurons induced very
similar changes to those observed after neutralization or genetic
ablation of Nogo-A (compare Fig. 3A with Fig. 5A): an increased
length of the longest neurite per cell (Fig. 5B), and a decreased
number of branches (Fig. 5D). The total neurite length per cell did
not significantly differ between the groups (Fig. 5C) and the
number of primary neurites per cell was not significantly changed
(control antibody, 3.81±0.18, n87; anti-NgR, 3.74±0.16, n92;
anti-Lingo1, 3.78±0.18, n89; Y27632, 3.69±0.19, n94). The
rectilinearity index was higher for neurons grown in presence of
anti-NgR or anti-Lingo1 antibodies or with Y27632 (control
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Fig. 4. Antibodies against NgR or Lingo1,
or ROCK blockade lead to increased
length and fasciculation of neurites in
DRG explant cultures. (A)Lumbar DRGs
explanted from wild-type newborn mice were
cultured for 5-7 days in the presence of either
anti-NgR or anti-Lingo1 antibodies, or with
the ROCK inhibitor Y27632. The presence of
any of these resulted in the formation of long,
straight and thick fibre bundles instead of the
interlaced network of fine processes formed
in control cultures. Scale bar: 300m.
(B-D)Antibodies against NgR or Lingo1, or
the blockade of ROCK resulted in an
increased length of radial outgrowth (B), a
reduced number of defasciculation points at
300m from the ganglia (C), and thicker
neurite bundles growing out of the DRGs (D).
Values represent means ± s.e.m. of 48–59
ganglia per condition from four independent











antibody, 0.796±0.0198, n87; anti-NgR, 0.938±0.0228, n92;
anti-Lingo1, 0.919±0.0186, n89; Y27632, 0.912±0.0139, n94;
P<0.001), and primary neurites sent out first branches further away
from the cell body than did the cells in control antibody-treated
cultures (control antibody, 10.74±0.8913 m, n87; anti-NgR,
25.79±2.271 m, n92; anti-Lingo1, 21.64±2.113 m, n89;
Y24632, 23.72±2.869 m, n94; P<0.0001). The number of
branches formed at large angles (81-90°) decreased and proportion
of branches formed at small angles (40-80°) from the parent branch
increased (Fig. 5E), thus pointing to a reduction in repulsive forces
between neurites.
On western blots of mouse brain lysates, a single band of ~51
kDa corresponding to NgR was detected by the anti-NgR antibody
(see Fig. S1B in the supplementary material). The antibody against
Lingo1 detected the full length Lingo1 protein at ~83 kDa, as well
as fragments at ~17 and ~34 kDa, which correspond to known
cleavage and degradation products (as stated by the manufacturer;
see Fig. S1C in the supplementary material).
Neutralization of neuronal Nogo-A leads to
progressive adhesion and neurite fasciculation
Time-lapse imaging was used to evaluate the sequence of events
leading to bundle formation upon neutralization of Nogo-A on the
surface of DRG neurons.
In the first set of experiments, we made time-lapse movies of
neurites growing out from Nogo-A KO or wild-type DRGs
treated either with control or 11C7 Nogo-A neutralizing
antibody, which was added at the time of plating. Neutralization
of Nogo-A either by function-blocking antibodies or by genetic
ablation resulted in highly bundled, straight neurites growing out
of the explants, as opposed to the highly dynamic plexus of fine,
intermingled neurites that appeared when DRG explants were
treated with the control antibody (see Movies 1-3 in the
supplementary material). The tips of the bundles advanced
rapidly; bundle formation seemed to increase over time (see
Movies 2, 3 in the supplementary material). Quantification of
fasciculation revealed a significantly reduced number of neurites
and bundles at the distance of 150 m from the DRG when
Nogo-A was neutralized or genetically ablated (wild
type+control antibody, 55.00±3.027, n18; 11C7, 37.33±3.177,
n20; Nogo-A KO, 34.71±3.283, n19; P<0.0001).
In the second set of time-lapse experiments, we investigated
whether delayed addition of an anti-Nogo-A antibody can cause
a shift from smaller to larger fascicles. We imaged wild-type
non-treated DRGs for 5 hours before the anti-Nogo-A antibody
11C7 was added. During that time, a complex plexus of thin,
interlaced neurites was formed (see Movie 4 in the
supplementary material). Soon after the addition of the 11C7
antibody, the plexus started to disappear, turning into bundles of
straight neurites (see Movie 4 in the supplementary material).
This movie also shows that the transformation was caused
mainly by neurites adhering to each other laterally, thus
progressively assembling into thicker fascicles. By the end of the
imaging period, 15 hours after addition of the antibody, most of
the neurites had assembled into bundles and the highly
elaborated neurite plexus was significantly reduced (see Movie
4 in the supplementary material). This increase in fasciculation
was confirmed by the reduction in the number of processes/
fascicles quantified at a distance of 150 m from the DRGs
following the neutralization of Nogo-A on the surface of neurites
with 11C7 antibody (wild type, 58.10±3.459, n21; 11C7,
34.86±3.192, n18; P<0.0001).
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Fig. 5. Antibodies against NgR or Lingo1, or ROCK blockade lead
to increased neurite length and decreased branch formation in
dissociated DRG neurons. (A)Dissociated DRGs of wild-type neonatal
mice were cultured for 10-24 hours in the presence of either control or
anti-NgR or anti-Lingo1 antibody. Length and straightness of DRG
neurites were increased, whereas their branching was reduced. The same
results were observed after Y27632 blockade of ROCK. Scale bar: 50m.
(B)Length of the longest neurite emanating from the DRG neurons was
increased after application of anti-NgR or anti-Lingo1 antibodies. The
same results were observed after Y27632 blockade of ROCK. (C)The total
length of all neurites of a given neuron was not altered in the presence of
either anti-NgR or anti-Lingo1 antibodies, or after Y27632 blockade of
ROCK activity. (D)Antibodies against NgR or Lingo1, or Y27632 blockade
of ROCK activity lead to a decreased number of branch points per
neuron. (E)Branches had smaller angles with their parental neurites after
application of anti-NgR or anti-Lingo1 antibodies. The same results were
observed after Y27632 blockade of ROCK. Values represent means ±
s.e.m. of 87-94 neurons per condition from four independent











Neutralization of Nogo-A in chicken embryos
results in aberrant peripheral nerve formation
The developing chick peripheral nervous system has served as an
excellent model system for studies of axon-axon interactions during
peripheral nerve formation and axonal pathfinding (Rafuse and
Landmesser, 2000; Tang et al., 1992; Tang et al., 1994). Therefore,
we turned to this experimental model to investigate the influence of
Nogo-A on peripheral fibre growth and branch formation in vivo.
Between stages 21 and 26 (HH21-26) (Hamburger and
Hamilton, 1951), i.e. during the time window of initial hindlimb
innervation, Nogo-AmRNA is expressed in both motor and sensory
neurons (Fig. 6A-C). Their axons reach the lumbar plexus at
HH21; they then go through a waiting period before they sort out
to select either a dorsal or a ventral pathway through the limb bud
(Wang and Scott, 2000). At HH23, they resume growth and extend
distally into the limb bud.
We injected the function-blocking anti-Nogo-A antibody 11C7
into the limb buds of chicken embryos in ovo. Injections started at
HH18, i.e. when motor and sensory axons leave the spinal cord and
the DRG respectively, but before they reach the plexus region.
Injections of 1.7 g of antibody were repeated every 12 hours until
the embryos were sacrificed at HH26. This approach was previously
used to analyze the effect of CAMs on hindlimb innervation and has
the advantage that the functional blockade can be targeted to the
region of interest and at the desired developmental stages
(Landmesser et al., 1988; Tang et al., 1994). Western blot analysis of
embryonic chicken HH24 brain lysates showed that in chick the
11C7 antibody also recognizes a single band of ~190 kDa, which
corresponds to Nogo-A (see Fig. S1A in the supplementary material).
Immunofluorescence at 4 hours after the antibody injection showed
a distribution over the entire limb, with minimal diffusion into the
contralateral limb (see Fig. S5 in the supplementary material).
Injection of the 11C7 antibody resulted in the failure of axons to
innervate the distal hindlimb correctly (Fig. 6D-H). Axons reached
the plexus, but often failed to sort out and leave the plexus area
(Fig. 6F-H). In some embryos, axons did not reach the distal part
of the hindlimb (Fig. 6G). The few axons that succeeded to extend
into the distal limb grew along aberrant pathways (Fig. 6F-H)
instead of choosing the appropriate dorsal or ventral trajectory to
reach the respective muscle mass. Neutralization of Nogo-A also
led to a dramatic decrease in branch formation of the nerves (Fig.
6, compare D,E with F-H).
For quantitative assessment the hindlimb innervation patterns
were grouped into three classes by two independent blinded
observers: normal innervation pattern, weak changes (some
pathfinding errors, but the innervation pattern was mainly normal),
or strong changes (only very few fibres present in the distal limb
bud; neither the crural nor the sciatic nerves were formed). Results
confirmed a highly aberrant hindlimb innervation in the anti-Nogo-
A antibody-injected embryos (Fig. 6I).
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Fig. 6. Neutralization of Nogo-A interferes with peripheral
nerve formation in the developing chicken embryo
hindlimb. (A-C)Localization of Nogo-A mRNA during spinal
cord development. In situ hybridization reveals Nogo-A
expression in motoneurons and dorsal root ganglia at the
lumbosacral spinal cord during the time of axon outgrowth at
HH21. Nogo-A continues to be expressed during pathfinding
and muscle innervation at HH24 and HH28. Importantly, Nogo-
A mRNA is absent from the ventral roots, indicating that
Schwann cells do not express Nogo-A. ROD, relative optical
density. Scale bar: 200m. (D-H)Dorsal (D,F,G) and anterior
(E,H) views of the limb bud are shown. Peripheral axons fail to
correctly innervate the distal limb in the absence of Nogo-A. In
limb buds injected with the anti-Nogo-A antibody 11C7, axons
mostly failed to leave the plexus area (F-H). In aged-matched
control limb buds that were injected with a control antibody
(D,E), axons formed the characteristic nerve trunks found in
non-treated control embryos (not shown). The sciatic nerve was
severely affected (arrows); in many embryos the nerve was not
formed at all (arrows in F). Fibres formed nerve bundles that
extended along aberrant pathways and often failed to reach the
distal part of the limb (arrow in G). White arrowhead in F and G
indicates a nerve extending along the posterior margin of the
limb bud that was less strongly affected in anti-NogoA
antibody-treated embryos, compare with white arrowhead in D.
The open arrowhead indicates the most anterior nerve of the
limb bud that normally branches extensively and straddles the
anterior edge of the limb bud by extending both dorsally and
ventrally, as seen in D,E. Scale bar: 500m. (I)Hindlimb
innervation patterns were classified into three groups: no
defect, weak abnormalities (distal nerves were disorganized but
could clearly be identified), and severe changes in the











We used the same approach to block the downstream effector
ROCK by repeated injections of Y27632. The effects on axonal
branching and sorting in the plexus region were less severe than
after blockage of Nogo-A function (see Fig. S6A-C in the
supplementary material). However, this might be explained by the
suboptimal concentration of the ROCK inhibitor in the embryo;
injection of 20 ng was lethal, and, even after injections of 3.35 ng
three times between HH18 and HH26, survival was decreased
compared with that of control embryos injected with PBS.
Nogo-A KO mouse embryos show increased
fasciculation and decreased branching of nerves
innervating fore- and hindlimbs
During the time of fore- and hindlimb innervation, between E10.5
and E15.5, Nogo-A mRNA was expressed both by motoneurons in
the spinal cord and sensory neurons in the DRGs (Fig. 7A). Levels
of Nogo-A mRNA increased in motoneurons and DRGs until
embryonic day 15.5 (Fig. 7A), i.e. during the time when axons
defasciculate in muscles and skin to form their stereotypical
branching patterns. Immunohistochemistry was consistent with the
in situ hybridization data (see Fig. S7 in the supplementary
material): motor and sensory axons stained intensely for Nogo-A
during the period when they grow from the plexus region into the
limb to form the major nerve trunks and muscle nerves (E11.5-
E13.5; see Fig. S7 in the supplementary material). Mesenchymal
cells and early forming myotubes were also Nogo-A positive, but
staining was clearly weaker than that seen in the nerves (see Fig.
S7 in the supplementary material).
We analyzed fore- and hindlimb innervation in wild-type and
Nogo-A KO embryos (E12.5-E13.5) by whole-mount
immunohistochemistry using an antibody against neurofilament
160.
Development of forelimb innervation
The median nerve, which innervates the palmar side of the hand,
starts to branch extensively at E12.5 in wild-type embryos (Fig. 7B).
Forelimb innervation and its analysis are schematically represented
in Fig. S8A in the supplementary material. Quantification showed
that the length of the median nerve arbour, starting from the hand
paddle, was not affected in Nogo-A KO embryos, whereas its width
was decreased (Fig. 7D). The dorsal side of the hand is innervated
by the radial and ulnar nerve (see Fig. S8A in the supplementary
material). The thickness of both nerves was increased in the Nogo-
A KO embryos (Fig. 7D). The length of the ulnar nerve was not
altered in the absence of Nogo-A (wild type, 249.3±12.67 m,
n12; Nogo-A KO, 238.1±11.628 m, n12). Reductions in the
branching pattern of both median and ulnar nerve were apparent in
Nogo-A KO embryos (Fig. 7B). At E12.5, both major and fine
nerve branches were missing in Nogo-A KO mice. At E13.5, the
median nerve grows distally and the digital nerves form. At this
developmental stage many smaller nerve branches were missing in
Nogo-A KO mice (number of branches: wild type, 25.126±3.988,
n12; Nogo-A KO, 15.866±2.344, n12; P0.0421). The superficial
network of cutaneous sensory nerves was markedly reduced in
Nogo-A mutants (Fig. 7B). Such major, obvious alterations in the
forelimb peripheral nerve formation were readily detectable in seven
out of 12 Nogo-A KO mouse embryos.
Development of hindlimb innervation
Distal hindlimb peripheral nerve development was significantly
affected by genetic inactivation of Nogo-A. At E12.5, Nogo-A
KO embryos showed a significantly increased width of the sciatic
nerve when compared with wild-type values (Fig. 7C,E). The
deep peroneal nerve extended an average 200 m past its branch
point in both genotypes (Fig. 7E). Its width was more than
doubled in Nogo-A KO embryos (Fig. 7C,E). The superficial
peroneal nerve length was not significantly altered in the absence
of Nogo-A (Fig. 7E), whereas the number of its branches was
reduced (Fig. 7C).
At the same developmental stage, the tibial nerve width was
increased in Nogo-A KO embryos (Fig. 7E) compared with in
wild-type embryos. Its arbour length was similar between the two
genotypes, but the arbour width and its complexity were
significantly decreased in the Nogo-A KO embryos (Fig. 7E). At
E13.5, the tibial nerve subdivides proximally into two major nerve
trunks and distally into five branches to innervate the plantar
muscles of the toes (see Fig. S8B in the supplementary material).
In Nogo-A KO embryos, bifurcation of the nerve into the two
major branches was disrupted (Fig. 7C) and its branching was
markedly reduced (number of branches: wild type, 28.736±4.638,
n12; Nogo-A KO, 17.664±3.254, n12; P0.0375). The tibial
nerve terminal arbour in Nogo-A KO animals appeared to be more
sparsely populated with nerve branches than in wild-type
littermates, suggesting that some constituents of the tibial nerve
were missing (Fig. 7C). The penetrance of this phenotype was
incomplete; changes in the development of the hindlimb peripheral
nerves were observed in eight out of 12 Nogo-A KO embryos.
These results, together with those obtained from the chick
experiments, demonstrate that perturbation of Nogo-A function
produces characteristic changes in peripheral nerve formation,
thickness and branching.
DISCUSSION
The inactivation of Nogo-A by gene ablation or by function-
blocking antibodies in cultured DRGs led to an increased length of
outgrowing neurites, a decrease in branch formation, and an
increase in fasciculation of neurites. Very similar results were
obtained when DRGs were treated with antibodies against NgR or
Lingo1, or with the ROCK blocker Y27632. Acute in ovo
neutralization of Nogo-A in the developing hindlimb of chicken
embryos led to the failure of many axons to leave the sciatic
plexus, increased fasciculation and an absence of major nerve
branches. In Nogo-A KO mouse embryos, ablation of Nogo-A
likewise caused increased fasciculation and reduced branching of
peripheral nerves. Taken together, these results suggest an
important role for Nogo-A in peripheral nervous system
development.
Nogo-A was purified and characterized as the first CNS myelin
neurite growth inhibitory protein and was shown to be present on
the cell surface (in addition to a large intracellular pool) with its N-
terminal, Nogo-A-specific region facing the extracellular space
(Caroni and Schwab, 1988; Chen et al., 2000; Dodd et al., 2005;
Huber et al., 2002; Oertle et al., 2003). Surprisingly, Nogo-A was
also found in neurons, where its levels are high during development
but lower or undetectable in the adult nervous system, except for
in regions with a high morphological and physiological plasticity
(Huber et al., 2002; Hunt et al., 2003; Josephson et al., 2001; Wang
et al., 2002). Signalling via a receptor complex containing NgR,
Lingo1, p75/TROY and possibly PirB, Nogo-A activates Rho-A
and ROCK and participates in rearrangements of the actin
cytoskeleton of the growth cone, resulting in neurite outgrowth
inhibition and neurite repulsion (Fournier et al., 2000; Luo et al.,
1993; Montani et al., 2009). Our in vitro results are best explained
by an anti-adhesive/repulsive cell surface action of Nogo-A on
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Fig. 7. Nogo-A KO mouse embryos show defects in the development of fore- and hindlimb innervation. (A)Expression of Nogo-A during
mouse spinal cord development shown by in situ hybridization. Nogo-A mRNA is present in sensory neurons of dorsal root ganglia and
motoneurons in the lumbar spinal cord of the E10.5 mouse embryo. Expression of Nogo-A increases until E15.5. ROD, relative optical density. Scale
bars: 100m, E10.5-E12.5; 200m, E15.5. (B)Whole-mount anti-neurofilament 160 immunostaining of wild-type and Nogo-A KO forelimbs at
E12.5 and E13.5. At E12.5, thickness of the ulnar nerve was slightly increased in Nogo-A KO embryos (open arrows, upper panel), whereas its
branching was decreased (open arrowhead, upper panel). Branching of the median nerve arbour was markedly reduced at both E12.5 and E13.5 in
Nogo-A KO embryos (arrows, upper and middle panels). At E13.5, a reduction in the branching pattern of sensory cutaneous nerves was apparent;
both major and fine branches were missing (arrow, lower panel). u.n., ulnar nerve; m.n., median nerve; s.c.n., sensory cutaneous nerves. Scale bar:
150m. (C)Innervation of wild-type and Nogo-A KO hindlimbs at E12.5 and E13.5. The width of the sciatic nerve and of its deep peroneal branch
were increased in the absence of Nogo-A (open arrow and arrowhead, respectively; upper panel), whereas branching of the superficial peroneal
nerve was reduced (arrow; upper panel). At E13.5, the tibial nerve divides into two major nerve trunks in wild-type embryos (arrows, lower panel).
This bifurcation of the tibial nerve was disrupted in the absence of Nogo-A (arrow; lower panel) and its thickness was increased (open arrows, lower
panel). s.n., sciatic nerve; t.n., tibial nerve. Scale bar: 150m. (D)Quantitation of the length and width of forelimb innervating nerves in wild-type
and Nogo-A KO E13.5 embryos. UNW, ulnar nerve width; RNW, radial nerve width; MAW, median nerve arbour width; MAL, median nerve arbour
length. Values represent means ± s.e.m. of 12 embryos per condition; *P<0.05, Student’s t-test. (E)Quantitation of the length and width of
hindlimb innervating nerves in wild-type and Nogo-A KO E13.5 embryos. TNW, tibial nerve width; TAL, tibial nerve arbour length; TAW, tibial nerve
arbour width; SNW, sciatic nerve width; SPNL, superficial peroneal nerve length; DPNL, deep peroneal nerve length; DPNW, deep peroneal nerve










neighbouring neurites and cells. Fasciculation and branching are
crucially dependent upon adhesive and repulsive interactions
between the neurites themselves, as well as with the surrounding
tissue and matrix components. Removal or inactivation of Nogo-A
or Nogo-A signalling, e.g. by blocking the active site or by
sterically interfering with ligand-receptor binding by a bulky IgG
antibody binding to sequences of Nogo-A or of the receptor
components NgR or Lingo1, lead to exaggerated adhesion and,
thereby, increased fasciculation in the dense neurite plexus of DRG
explant cultures and of growing peripheral nerves in embryos in
vivo. Unbalanced adhesive interactions might also be responsible
for the fact that many neurites were unable to leave the sciatic
plexus in the chicken embryos injected with anti-Nogo-A
antibodies; within the plexus region, bundles of motor and sensory
axons need to defasciculate in order to form the new fascicles
destined to innervate individual muscle groups (Milner et al., 1998;
Tosney and Landmesser, 1985). Likewise, the inability of neurites
to leave a fibre bundle could be responsible for the conspicuous
absence of branches of limb nerves in antibody-treated chicken and
in Nogo-A KO mouse embryos. Muscle nerve formation in
Drosophila is crucially dependent on defasciculation (Van Vactor,
1998). In the chicken embryo, removal of the repulsive component
PSA from NCAM resulted in an increased bundling of axons and
a concomitant failure of branching of peripheral nerves
(Landmesser et al., 1990; Rafuse and Landmesser, 2000; Tang et
al., 1992; Tang et al., 1994). Controlled adhesion/repulsion seems
therefore to be essential for the ability of neurites to form branches
and/or for the ability of branches to leave a fascicle or its parent
neurite. Interestingly, a marked decrease of branch formation was
also seen in dissociated DRG neurons cultured at single-cell
density. The increase in the length of the individual neurites
corresponded to the decrease in the number of branches (identical
total neurite length per cell). Repulsive interactions between
dividing growth cones or branch sprouts and the parent neurite
were suggested for repulsors such as ephrins (McLaughlin et al.,
2003), and slit is known to enhance branch formation of ingrowing
sensory fibres in the developing spinal cord (Wang et al., 1999).
The almost 90° angles formed by many branches are consistent
with an important role of repulsive interactions between growing
processes of a single neuron. These branch angles were
significantly smaller in Nogo-A KO or antibody-treated cells,
suggesting that Nogo-A is an important repulsive factor required
for branch formation and branch direction. The clear segregation
observed when wild-type and Nogo-A KO dissociated DRG
neurons were mixed is consistent with differences in
adhesive/repulsive cell surface properties exerted non-cell
autonomously in trans during cell-cell interactions. However,
owing to other players and possible compensations, the detailed
mechanism could be complex.
In DRG cultures, neutralization of the Nogo-A receptor
components NgR or Lingo1 by the respective antibodies, or
blockade of the Rho effector ROCK by the Y27632 compound,
phenocopied the results observed after Nogo-A neutralization or
KO, thus suggesting an NgR-Rho/ROCK-dependent mechanism of
action for Nogo-A in neurite fasciculation and branching. In vivo,
the acute downregulation of Nogo-A in embryonic chick hindlimbs
also caused major defects of peripheral nerve formation. Although
inhibition of the Rho effector ROCK in vivo did not reproduce the
full extent of the phenotype seen after inhibition of Nogo-A by
function-blocking antibody, the observed phenotype is consistent
with a role of ROCK signalling downstream of Nogo-A. Thus,
both Nogo-A and ROCK are required for the sorting of axons in
the sciatic plexus of the developing hindlimb. The analysis of fore-
and hindlimb peripheral nerves in Nogo-A KO mouse embryos
showed missing branches and thicker nerves, although unlike in the
chicken embryo, most main nerve trunks were present in the Nogo-
A KO embryos. These characteristic changes were mostly transient
and no longer observed at E15.5 (see Fig. S9 in the supplementary
material). However, at late developmental stages only major
defects can be readily and reproducibly observed and quantified.
The less severe phenotype of Nogo-A KO mice compared with that
of anti-Nogo-A antibody-injected chicken embryos might also be
related to a compensatory upregulation of other repulsive
molecules. Indeed, increased levels of mRNA or protein for several
ephrins and semaphorins, and for some of their receptors, have
been observed in Nogo-A KO mice (data not shown). Although in
adult Nogo-A KO mice Nogo-A deletion resulted in Nogo-B
upregulation, this was not the case during embryonic development
(see Fig. S10 in the supplementary material). Nogo-A was also
weakly expressed by embryonic muscles at that age. There, it
might provide additional help in keeping the growing axons en
route by forming a repulsive environment. Absence of muscle
Nogo-A would then lead to defasciculation and aberrant branching;
however, such a phenotype was not observed here, indicating that
Nogo-A on the neurons and neurites themselves might play the
more important role.
The present results show a key role of Nogo-A/Nogo receptor
signalling in fascicle formation and branching of developing
peripheral neurons in vitro and in vivo. The observations are best
explained by repulsive/anti-adhesive effects exerted by cell surface
Nogo-A via the Nogo receptor complex and Rho-ROCK activation.
These effects counter-balance adhesive/attractive interactions in the
concert of axonal guidance adhesion, and recognition molecules
and mechanisms. Nogo-A thus joins the families of developmental
repulsive/inhibitory regulators of neurite growth. As development
proceeds, Nogo-A assumes a function as a growth restrictor and
stabilizer of the maturing and adult nervous system, whereby its
expression shifts to oligodendrocytes and the CNS becomes its
main site of action (Gonzenbach and Schwab, 2008; Huber et al.,
2002).
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